HEATHER THOMAS: Open Payments
NPI 1497325344 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$808 in 40 payments from 15 companies in 2025. Trend: 2023 $972 · 2024 $1,064 · 2025 $808
Food & beverage: $808
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $260 |
| ABBVIE INC. | 4 | $85 |
| Lilly USA, LLC | 3 | $81 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| Astellas Pharma US Inc | 3 | $62 |
| Corium, LLC | 3 | $44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
Products named: Wegovy, Ozempic, BREZTRI, Veozah, ZEPBOUND, UBRELVY, Azstarys, XIFAXAN.
Industry payments across IN — which companies pay providers there.
